# Treating Severe Brain-injured Patients With Apomorphine

> **NCT03623828** · PHASE2 · UNKNOWN · sponsor: **University of Liege** · enrollment: 8 (actual)

## Conditions studied

- Disorder of Consciousness

## Interventions

- **DRUG:** Apomorphine Hydrochloride 50Mg/10mL Prefilled Syringe

## Key facts

- **NCT ID:** NCT03623828
- **Lead sponsor:** University of Liege
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-03
- **Primary completion:** 2021-04-28
- **Final completion:** 2022-11-13
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2022-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03623828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03623828, "Treating Severe Brain-injured Patients With Apomorphine". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03623828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*